fbm0aag3 | Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/fbm0aag3_hasAnnotation_C0003015> <https://research.tib.eu/covid-19/entity/fbm0aag3_hasAnnotation_C0815017>
?:creator	<https://research.tib.eu/covid-19/entity/Liu%2C_Xiao%3B_Long%2C_Chuyan%3B_Xiong%2C_Qinmei%3B_Chen%2C_Chen%3B_Ma%2C_Jianyong%3B_Su%2C_Yuhao%3B_Hong%2C_Kui>
?:doi	10.1002/clc.23473
?:doi	<https://research.tib.eu/covid-19/entity/10.1002/clc.23473>
?:journal	Clin_Cardiol
?:license	cc-by
?:pdf_json_files	document_parses/pdf_json/9f437588ab52dd1c8bc8b2c74421853bdfcf6d17.json
?:pmc_json_files	document_parses/pmc_json/PMC7803360.xml.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7803360>
?:pmid	<https://research.tib.eu/covid-19/entity/33180964.0>
?:pmid	33180964.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:sha_id	<https://research.tib.eu/covid-19/entity/9f437588ab52dd1c8bc8b2c74421853bdfcf6d17>
?:source	Medline; PMC
?:title	Re: Is there a difference in the effect between the angiotensin‐converting enzyme inhibitor and angiotensin‐receptor blocker on the COVID‐19?
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-11-12

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/fbm0aag3>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/fbm0aag3>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all